Summit Therapeutics (SMMT) Other Working Capital Changes (2017 - 2025)
Historic Other Working Capital Changes for Summit Therapeutics (SMMT) over the last 9 years, with Q3 2025 value amounting to -$3.7 million.
- Summit Therapeutics' Other Working Capital Changes fell 444767.44% to -$3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 57673.99%. This contributed to the annual value of $7.9 million for FY2024, which is 13107.28% up from last year.
- Per Summit Therapeutics' latest filing, its Other Working Capital Changes stood at -$3.7 million for Q3 2025, which was down 444767.44% from $1.9 million recorded in Q2 2025.
- In the past 5 years, Summit Therapeutics' Other Working Capital Changes registered a high of $8.9 million during Q4 2024, and its lowest value of -$3.7 million during Q3 2025.
- Over the past 5 years, Summit Therapeutics' median Other Working Capital Changes value was -$1.0 million (recorded in 2021), while the average stood at -$102894.7.
- Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 676466.17% in 2024, then tumbled by 444767.44% in 2025.
- Over the past 5 years, Summit Therapeutics' Other Working Capital Changes (Quarter) stood at -$1.0 million in 2021, then soared by 127.35% to $276000.0 in 2022, then tumbled by 148.19% to -$133000.0 in 2023, then skyrocketed by 6764.66% to $8.9 million in 2024, then tumbled by 142.18% to -$3.7 million in 2025.
- Its Other Working Capital Changes stands at -$3.7 million for Q3 2025, versus $1.9 million for Q2 2025 and -$1.8 million for Q1 2025.